At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
JUNS Jupiter Neurosciences
Not Yet Opened 07-15 16:00:00 EDT
0.1785
+0.0005
+0.28%
盘后0.1787
+0.0002+0.11%
19:41 EDT
High0.1825Low0.1700Vol401.13K
Open0.1740D1 Closing0.1780Amplitude7.02%
Mkt Cap8.61MTradable Cap4.81MTotal Shares48.22M
T/O70.46KT/O Rate1.49%Tradable Shares26.94M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Jupiter Neurosciences Names Former White House Economic Adviser Tomas Philipson to Board
Reuters  ·  07-07
Jupiter Neurosciences Names Former White House Economic Adviser Tomas Philipson to Board
Jupiter Neurosciences Strengthens Board with Appointment of DR. Tomas J. Philipson
THOMSON REUTERS  ·  07-07
Jupiter Neurosciences Strengthens Board with Appointment of DR. Tomas J. Philipson
Jupiter Neurosciences Appoints Tomas J. Philipson to Board
Reuters  ·  07-01
Jupiter Neurosciences Appoints Tomas J. Philipson to Board
Top Premarket Decliners
MT Newswires Live  ·  06-29
Top Premarket Decliners
Jupiter Neurosciences - Files for Resale of up to 16 Mln Shares by Selling Stockholder - SEC Filing
THOMSON REUTERS  ·  06-27
Jupiter Neurosciences - Files for Resale of up to 16 Mln Shares by Selling Stockholder - SEC Filing
Jupiter Neurosciences Announces Board Member Resignation and Vacancy
TIPRANKS  ·  06-22
Jupiter Neurosciences Announces Board Member Resignation and Vacancy
Jupiter Neurosciences director Allison Brady resigns from board, committees
Reuters  ·  06-22
Jupiter Neurosciences director Allison Brady resigns from board, committees
Sk Pharmteco Announces Strategic Collaboration With Orphan Therapeutics Accelerator
Reuters  ·  06-18
Sk Pharmteco Announces Strategic Collaboration With Orphan Therapeutics Accelerator
Jupiter Neurosciences Promotes Silva to COO and President
TIPRANKS  ·  06-06
Jupiter Neurosciences Promotes Silva to COO and President
Jupiter Neurosciences commences patient enrollment in RESET trial
TIPRANKS  ·  05-27
Jupiter Neurosciences commences patient enrollment in RESET trial
Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a Reset Trial in Parkinson’s Disease
THOMSON REUTERS  ·  05-27
Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a Reset Trial in Parkinson’s Disease
Jupiter Neurosciences closes $2 million registered direct offering
Reuters  ·  05-22
Jupiter Neurosciences closes $2 million registered direct offering
Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering
THOMSON REUTERS  ·  05-22
Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering
Jupiter Neurosciences Inc - Files for Offering of 7.14 Mln Shares of Common Stock - SEC Filing
THOMSON REUTERS  ·  05-21
Jupiter Neurosciences Inc - Files for Offering of 7.14 Mln Shares of Common Stock - SEC Filing
Jupiter Neurosciences prices registered direct offering at USD 2 million
Reuters  ·  05-21
Jupiter Neurosciences prices registered direct offering at USD 2 million
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
THOMSON REUTERS  ·  05-21
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
Jupiter Neurosciences Inc - to Buy Exclusive U.S. Rights to Ala-002 From Pharmala Biotech
THOMSON REUTERS  ·  05-20
Jupiter Neurosciences Inc - to Buy Exclusive U.S. Rights to Ala-002 From Pharmala Biotech
Jupiter Neurosciences agrees to pay $3.33 million for exclusive US rights to PharmAla’s ALA-002
Reuters  ·  05-20
Jupiter Neurosciences agrees to pay $3.33 million for exclusive US rights to PharmAla’s ALA-002
Jupiter Neurosciences Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $18.652K Miss $225.000K Estimate
Benzinga  ·  05-15
Jupiter Neurosciences Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $18.652K Miss $225.000K Estimate
Jupiter Neurosciences Q1 FY26 net loss widens 35% to $2.06 million
Reuters  ·  05-15
Jupiter Neurosciences Q1 FY26 net loss widens 35% to $2.06 million

Introduction

Company Name.
Jupiter Neurosciences
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--